The ABCB1 C3435T Polymorphism is Associated with Triglyceride Reduction in Atorvastatin-treated Uygur Patients with Coronary Heart Disease and Dyslipidemia: An Observational Study
Article in Endocrine Metabolic & Immune Disorders - Drug Targets (January 2023)